![]() |
|
|
Vol. 291, Issue 1, 204-212, October 1999
Graduate School of Pharmaceutical Sciences, University of Tokyo,
Hongo, Bunkyo-ku, Tokyo, Japan (Y.-H.H., Y.K., Y.S.); and Core Research
for Evolutional Science, and Technology (CREST), Japan Science and
Technology Corporation, Japan (Y.K., Y.S.)
The excretion and tissue distribution kinetics of a novel
antifolate, MX-68, were evaluated under conditions of a continuous steady-state infusion in Sprague-Dawley rats (SDRs). The biliary excretion clearance defined with respect to the hepatic concentration (CLbile, h) was much lower in Eisai hyperbilirubinemic rats
with a hereditary deficiency in canalicular multispecific organic anion transporter than that in SDRs, suggesting the involvement of
canalicular multispecific organic anion transporter in its transport
across the bile canalicular membrane. The CLbile, h in SDRs
increased as the infusion rate increased; this can be largely explained by saturation of the intracellular binding of MX-68. On the other hand,
the urinary excretion clearance defined with respect to the renal
concentration (CLurine, k) was comparable for the two strains but showed an increase and subsequent decrease as the renal
concentration increased. This nonlinear profile was also found even
when the CLurine, k was normalized by the unbound fraction in kidney. Therefore, this kinetic profile represents the saturation of
both reabsorption and secretion. Reabsorption of MX-68 in kidney was
supported by its saturable transport by renal brush border membrane
vesicles at an inward H+ gradient. The liver-to-plasma
unbound concentration ratio decreased as the steady-state plasma
concentration increased, suggesting that MX-68 is taken up by a
saturable mechanism or mechanisms. Thus, the saturation of transport
systems across several plasma membranes and intracellular binding in
both the liver and kidney produce the nonlinear disposition of MX-68.
This article has been cited by other articles:
![]() |
H. Komura and M. Iwaki NONLINEAR PHARMACOKINETICS OF PROPAFENONE IN RATS AND HUMANS: APPLICATION OF A SUBSTRATE DEPLETION ASSAY USING HEPATOCYTES FOR ASSESSMENT OF NONLINEARITY Drug Metab. Dispos., June 1, 2005; 33(6): 726 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Han, Y. Kato, Y. Watanabe, K. Terao, Y. Asoh, and Y. Sugiyama Carrier-Mediated Hepatobiliary Transport of a Novel Antifolate, N-[4-[(2,4-Diamminopteridine-6-yl)methyl]-3,4-dihydro-2H-1,4-benzothiazin-7-yl]carbonyl-L-Homoglutamic Acid, in Rats Drug Metab. Dispos., April 1, 2001; 29(4): 394 - 400. [Abstract] [Full Text] |
||||